日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficiency of single-pulse laser fragmentation of organic nutraceutical dispersions in a circular jet flow-through reactor

单脉冲激光破碎法在圆形喷射流通反应器中对有机营养保健品分散体的效率

Friedenauer, Tina; Spellauge, Maximilian; Sommereyns, Alexander; Labenski, Verena; Esatbeyoglu, Tuba; Rehbock, Christoph; Huber, Heinz P; Barcikowski, Stephan

Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency

SLC6A8 变异的新型校正剂:肌酸转运蛋白缺乏症的治疗机会

Lara N Gechijian, Giovanni Muncipinto, T Justin Rettenmaier, Matthew T Labenski, Victor Rusu, Lea Rosskamp, Leslie Conway, Daniel van Kalken, Liam Gross, Gianna Iantosca, William Crotty, Robert Mathis, Hyejin Park, Benjamin Rabin, Christina Westgate, Matthew Lyons, Chloe Deshusses, Nicholas Brandon,

Labeling Preferences of Diazirines with Protein Biomolecules

二氮杂环丙烯与蛋白质生物分子的标记偏好

West, Alexander V; Muncipinto, Giovanni; Wu, Hung-Yi; Huang, Andrew C; Labenski, Matthew T; Jones, Lyn H; Woo, Christina M

In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing

不可逆突变选择性 EGFR 抑制剂(保留野生型)的体外和体内表征

Robert Tjin Tham Sjin, Kwangho Lee, Annette O Walter, Aleksandr Dubrovskiy, Michael Sheets, Thia St Martin, Matthew T Labenski, Zhendong Zhu, Richland Tester, Russell Karp, Aravind Medikonda, Prasoon Chaturvedi, Yixuan Ren, Henry Haringsma, Jeff Etter, Mitch Raponi, Andrew D Simmons, Thomas C Hardin

Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy

α逆转录病毒载体:从致癌物到人类基因治疗的有用工具

Suerth, Julia D; Labenski, Verena; Schambach, Axel

S-adenosyl-l-methionine protection of acetaminophen mediated oxidative stress and identification of hepatic 4-hydroxynonenal protein adducts by mass spectrometry.

S-腺苷-L-蛋氨酸对乙酰氨基酚介导的氧化应激的保护作用以及通过质谱法鉴定肝脏4-羟基壬烯醛蛋白加合物

Brown James Mike, Kuhlman Christopher, Terneus Marcus V, Labenski Matthew T, Lamyaithong Andre Benja, Ball John G, Lau Serrine S, Valentovic Monica A

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC

发现一种 EGFR 突变选择性共价抑制剂,可克服 NSCLC 中 T790M 介导的耐药性

Annette O Walter, Robert Tjin Tham Sjin, Henry J Haringsma, Kadoaki Ohashi, Jing Sun, Kwangho Lee, Aleksandr Dubrovskiy, Matthew Labenski, Zhendong Zhu, Zhigang Wang, Michael Sheets, Thia St Martin, Russell Karp, Dan van Kalken, Prasoon Chaturvedi, Deqiang Niu, Mariana Nacht, Russell C Petter, Willi

Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans

使用 CC-292 抑制 Btk 可对小鼠和人类的活性进行早期药效学评估

Erica K Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T Labenski, Steven R Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I Freed, Russell C Petter, Alex Dubrovskiy, Juswinder Singh, William F Westlin

Initial interrogation, confirmation and fine mapping of modifying genes: STAT3, IL1B and IFNGR1 determine cystic fibrosis disease manifestation

初步探究、确认和精细定位修饰基因:STAT3、IL1B 和 IFNGR1 决定囊性纤维化疾病的表现。

Labenski, Heike; Hedtfeld, Silke; Becker, Tim; Tümmler, Burkhard; Stanke, Frauke

The frequency of 1,4-benzoquinone-lysine adducts in cytochrome c correlate with defects in apoptosome activation

细胞色素 c 中 1,4-苯醌-赖氨酸加合物的频率与凋亡小体活化缺陷相关

Ashley A Fisher, Matthew T Labenski, Srinivas Malladi, John D Chapman, Shawn B Bratton, Terrence J Monks, Serrine S Lau